Health News Archive - May 17, 2010
SCHAUMBURG, Ill., May 17 /PRNewswire-USNewswire/ -- Despite the fact that skin cancer is the only cancer that can be seen on the surface of the skin, a new survey by the American Academy of Dermatology (Academy) reports that a large number of people are not taking the time to examine their skin for any changes that could be warning signs of skin cancer or seeing a health-care provider for a skin cancer screening.
LEUVEN, Belgium and LUND, Sweden, May 17, 2010 /PRNewswire-FirstCall/ -- - Trial to Study Patients with Colorectal and Ovarian Cancer ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (OMXS: BINV) announce today that their partner Roche (SIX: RO, ROG; OTCQX: RHHBY) will begin an imaging study with the novel anti-cancer antibody TB-403 (RG7334) in patients with metastatic, treatment-refractory, colorectal and ovarian cancers.
SEATTLE, May 17 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
STOCKHOLM, May 17, 2010 /PRNewswire/ -- Axelar AB, a Karolinska Development portfolio company, today announces that a submitted abstract has been accepted to the ASCO meeting in Chicago, June 2010. The abstract containing preliminary clinical data will be publicly released on ASCO's website, http://www.asco.org on Thursday, May 20, 2010 at 6:00 PM (EDT). "We are pleased that the abstract containing a preliminary update of the favorable clinical data has been accepted by 2010 Annual Meeting of the American Society of Clinical Oncology", says Johan Harmenberg, CEO Axelar AB. About Axelar Axelar is a Swedish biotech company founded in 2003.
TAI'AN, China, May 17 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc.
LAIYANG, China, May 17 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc.
SAN DIEGO, May 17 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of science-based solutions to oxidative stress, announced today unaudited third quarter fiscal 2010 financial and operating results. (Logo: http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO) The Company recorded approximately $2.7 million net revenue for the three month period ended March 31, 2010, which represents a 316% increase over net revenue from the same quarter last fiscal year, and an 11% increase over the second fiscal quarter of 2010.
JEFFERSON CITY, Mo., May 17 /PRNewswire/ -- While much attention is devoted to reducing medical errors in hospitals, there's a lesser focus on rooting out patient care errors in emergency medical services (EMS).
SOUTH SAN FRANCISCO, Calif., May 17 /PRNewswire-FirstCall/ -- Titan Pharmaceuticals, Inc.
ORLANDO, Fla., May 17 /PRNewswire/ -- The SAPÂ® Customer Relationship Management (SAP CRM) application, configured and managed by RunE2E and hosted in a secure, private cloud enabled by Freudenberg IT (FIT), is powering the complex sales and marketing needs of Cryo-Cell International, Inc., a pioneering healthcare company specializing in stem cell cryopreservation services.